Daily News cover art

Daily News

Daily News

By: Daily News
Listen for free

About this listen

 Daily News brings you the most important global headlines — fast, accurate, and insightful.
Stay informed with deep analysis, trusted updates, and balanced coverage from around the world.
Every episode is crafted to help you understand what really matters today.
🌍 Politics • Technology • Science • Business • Culture
Copyright Daily News Politics & Government
Episodes
  • BP's Winning Strategy Against Venture Global LNG

    BP's Winning Strategy Against Venture Global LNG
    Nov 4 2025
    Details a major legal and commercial conflict within the Liquefied Natural Gas (LNG) sector, centered on disputes between several global energy firms and U.S. producer Venture Global LNG. The article highlights that BP recently won a significant arbitration case against Venture Global — which had sought over $1 billion in damages — after successfully arguing that the company engaged in unfair conduct by withholding contracted cargoes.
    This outcome contrasts with a similar case involving Shell, which lost its arbitration after failing to make the same unfair behavior claim. Other energy firms, including Galp, Edison, and Repsol, have launched parallel legal actions accusing Venture Global of diverting LNG cargoes to the more lucrative spot market amid soaring prices following the Russian invasion of Ukraine.
    Venture Global, however, defends its actions by asserting that its Louisiana export terminal was still in a commissioning phase, meaning it was not yet bound to deliver cargoes under its long-term supply contracts. Nonetheless, the BP tribunal found that Venture Global had failed to act as a “reasonable and prudent operator,” reinforcing accusations that the company exploited market conditions at the expense of contractual partners.
    Show More Show Less
    11 mins
  • BP Beats Profit Forecasts, Castrol Sale Undetermined

    BP Beats Profit Forecasts, Castrol Sale Undetermined
    Nov 4 2025
    Outlines BP’s third-quarter earnings, highlighting that the company reported a smaller-than-expected drop in underlying profit, supported by strong performances across all divisions, particularly its refining operations. Despite exceeding analyst expectations, BP offered no major update on the planned divestment of its Castrol lubricants business, which is part of a broader $20 billion asset sale initiative designed to cut debt and streamline operations.
    CEO Murray Auchincloss emphasized that recent exploration successes — including the Bumerangue oil field discovery — demonstrate BP’s long-term production potential within its existing portfolio. The company reaffirmed its strategy of boosting profitability through efficiency and cost reductions, noting that it expects to finalize around $5 billion in asset sale agreements this year, primarily involving the sale of minority stakes in U.S. onshore pipeline assets.
    Show More Show Less
    13 mins
  • Pfizer and Novo Nordisk's Obesity Drug Bidding War

    Pfizer and Novo Nordisk's Obesity Drug Bidding War
    Nov 4 2025
    Describes an intensifying bidding war between Pfizer and Novo Nordisk over the obesity drug developer Metsera, which has escalated into a legal and financial showdown between the two pharmaceutical giants. Novo Nordisk recently made a $10 billion counteroffer, surpassing Pfizer’s previously accepted lower bid and prompting Pfizer to respond with an $8.1 billion revised offer alongside lawsuits accusing Metsera of breach of contract and antitrust violations.
    A Delaware judge declined to halt the bidding process, noting that the competitive auction appeared to be benefiting Metsera’s shareholders, though legal challenges from Pfizer remain active. The acquisition is strategically pivotal: Pfizer views Metsera as a means to reestablish its footing in the fast-growing obesity market after recent setbacks, while Novo Nordisk sees the deal as essential to maintain its market dominance against fierce competition from Eli Lilly.
    In parallel with the dispute, Pfizer raised its full-year profit outlook, signaling underlying business resilience despite slumping sales of its COVID-19 products.
    Show More Show Less
    13 mins
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.